ArunA Bio says it will use the funding to support the development of its neural exosome delivery platform and neural exosome therapies for treating neurodegenerative diseases such as ALS, Huntington’s Disease and stroke
from Bizjournals.com Feed (2019-07-18 12:47:42) https://www.bizjournals.com/atlanta/news/2019/07/29/athens-biotech-firm-treating-als-strokes-raises.html?ana=brss_609
Mold Remediation Pros
No comments:
Post a Comment